The authors applied a time-series approach to assess the temporal trend of racial disparity in chlamydia prevalence between young, socioeconomically disadvantaged blacks and whites entering the US National Job Training Program. Racial disparity was defined as the arithmetic difference between age group-, specimen type-, and region of residence-standardized chlamydia prevalences in blacks and whites. A regression with autoregressive moving average errors model was employed to adjust for serial correlation. Data from 46,849 women (2006-2008) and 136,892 men (2004-2008) were analyzed. Racial disparity significantly decreased among women (by an average of 0.122% per 2-month interval; P < 0.05) but not among men (À0.010%, P ¼ 0.57). Chlamydia prevalence significantly declined for black women (À0.139% per 2-month interval; P ¼ 0.004), black men (À0.045%, P < 0.001), and white men (À0.035%, P ¼ 0.002) but not for white women (À0.028%, P ¼ 0.413). Despite the decreases among black women and black men, the black-white disparities remained high for both sexes; in 2008, the racial disparity was 8.1% (95% confidence interval: 6.8, 9.3) for women and 9.0% (95% confidence interval: 8.4, 9.6) for men. These findings suggest that current chlamydia control efforts may be reaching young black men and women but need to be scaled up or modified to address the excess risk among blacks.
Chlamydia infection is the most commonly reported notifiable disease in the United States (1) . If untreated, chlamydial infections can progress to serious reproductive and other health problems with both short-term and longterm consequences (2) . Because chlamydia infection is commonly asymptomatic (3), screening is the only effective way to detect and treat the majority of cases (4) . Public health officials have recommended annual screening for chlamydia infection for all sexually active women under 26 years of age since the 1990s (5-7). Between 2000 and 2007, chlamydia screening coverage rates generally increased among sexually active women aged 16-25 years who accessed health care (8) . No formal national recommendations exist for screening men for chlamydia.
The prevalence of chlamydia infection is consistently higher among blacks than among whites (1, (9) (10) (11) (12) (13) . For example, data from the National Health and Nutrition Examination Survey, a nationally representative survey of noninstitutionalized US civilians, indicated that during 1999-2002, chlamydia prevalence among participants aged 14-39 years was 6.4% for blacks and 1.5% for whites (9) ; data from the National Longitudinal Study of Adolescent Health from 2001-2002 indicated a prevalence of 12.5% among blacks and 1.9% among whites (12) . Monitoring changes in chlamydia prevalence disparity by population subgroup over time is essential for planning and evaluating chlamydia prevention efforts and for resource allocation.
Few studies have analyzed racial disparity in chlamydia infection temporally. National case report data indicate that chlamydia case rates increased among both female and male blacks and whites from 2004 through 2008 (1) . The excess chlamydia case rate per 100,000 population for blacks as compared with whites increased from 1,505 cases per 100,000 population in 2006 to 1,793 cases per 100,000 in 2008 among women and from 581 cases per 100,000 population in 2004 to 849 cases per 100,000 in 2008 among men (1) . However, case report data may not reflect the true burden of disease. A combination of factors, such as expansion of chlamydia screening activities and use of increasingly sensitive diagnostic tests, could mask true changes over time (1) . To better ascertain trends in disease burden, other prevalence data sources must be considered. The US National Job Training Program (NJTP) is an occupational training program serving socioeconomically disadvantaged young men and women, who are universally offered chlamydia screening at their entrance health examination (10, 11, 14) . Because of the NJTP's relatively stable population, screening program, and consistent use of known chlamydia test technologies for several years, NJTP data provide a unique opportunity to estimate the changes in chlamydia prevalence and to examine the racial disparity trend in chlamydia infection.
The commonly used method for measuring changes in health outcome disparity over time, recommended by the National Center for Health Statistics and other researchers, is to compare disparity measures at 2 points in time (15) (16) (17) . Since only 2 disparity measures from 2 time points are utilized for analysis, the interim data between the 2 time points are usually ignored or incorporated into either of the 2 point-in-time disparity measures. These approaches can be widely used because of their simplicity and flexibility. However, more complete analyses of temporal trends in disparity usually require a sequence of measures to accurately assess the trend across a specified time period. When interim data between 2 widely spaced time points are ignored or are simply incorporated into either of 2 pointin-time disparity measures, information is lost, and inaccurate conclusions might be made. Time-series analysis methods can be used to efficiently include all available disparity measurements over time. When disparity time series are serially correlated, time-series analysis can also be used to adjust for the serial correlation to avoid invalid statistical inference.
In the current study, we analyzed the temporal trend of the absolute disparity in chlamydia prevalence between blacks and whites by sex using NJTP health-services data. To improve the accuracy and validity of the estimates of changes in racial disparity over time, we employed a time-series approach to analyzing a series of disparity measurements modeled by regression method; when serial correlation was detected, we used a regression with autoregressive moving average (ARMA) errors model to take the correlation into account.
MATERIALS AND METHODS

Data and measures
We analyzed health-services data from the NJTP for 2 time periods: March 2006 through December 2008 for women and January 2004 through December 2008 for men. Detailed information describing the NJTP and its health-service practices has been presented elsewhere (10, 11, 13, 18 (19, 20) . Relatively few women were tested by SDA technology during January and February 2006, so screening data from those 2 months were excluded. During the study periods, all men and 99.6% of women who had a test for chlamydia underwent an SDA test. Eligible subjects were defined as non-Hispanic women and men entering the NJTP during the study period who were black or white, were aged 16-24 years, had a known region of residence, and had results (positive or negative) from chlamydia SDA tests conducted during their entrance health examination.
Chlamydia prevalence in 4 sex-and-race subgroupsblack women, white women, black men, and white menwas measured. Since sufficient numbers of persons were screened during each 2-month interval to get reliable estimates of chlamydia prevalence, we aggregated the data in 2-month intervals to obtain a larger sample size (number of time intervals) in order to increase statistical power for testing trends in regression models. Bimonthly chlamydia prevalence was defined as the proportion of entrants in each sex-and-race subgroup with positive tests for Chlamydia trachomatis among all entrants in each subgroup tested during each 2-month interval. Thus, 4 chlamydia prevalence time series were generated in 17 (black women and white women from 2006-2008) or 30 (black men and white men from 2004-2008) time intervals. Since chlamydia test positivity is associated with the characteristics of a population screened, such as age group, region of residence, or specimen type (11, (21) (22) (23) , direct standardization was used to account for the variable distributions of these factors over time. Bimonthly prevalence rates adjusted for age group (16-19 years or 20-24 years), US Census region of residence at entrance (Midwest, Northeast, South, or West), and specimen type (women only: urine or cervix) were calculated. All eligible women or men were respectively used as their own standard populations.
We used absolute disparity to address the questions, How much higher is the chlamydia prevalence rate among blacks compared with the rate among whites (24) ? and, Is the disparity difference changing over time? The absolute disparity measures the excess risk for blacks (compared with whites), who would benefit from the elimination of a disparity. Absolute disparity between blacks and whites by sex was calculated as the adjusted chlamydia prevalence among blacks minus the adjusted prevalence among whites for each time interval. To fully interpret the meaning of the changes in disparity over time, beyond just the disparity trends, we also examined the changes in prevalence for each comparison group over time. Chlamydia prevalence and black-white disparity in chlamydia prevalence in 2008, the most recent year for which data are available, were also estimated.
To examine temporal trends in disparity by Census region, we used a 6-month time interval to obtain a sufficient number of observations for each interval. For consistency, all estimated rates of change in disparity are presented using a 2-month interval.
Statistical analysis
A regression with ARMA errors model (25, 26) or a simple linear regression model was employed to evaluate the temporal trends in black-white disparity in chlamydia prevalence and sex-and race-specific chlamydia prevalence. We evaluated prevalence in 2-month intervals within a calendar year and did not find evidence of any seasonality for chlamydia prevalence. Likewise, we detected no seasonality effects in the disparity in chlamydia prevalence. When data from an error term of a linear regression model were serially correlated, an ARMA noise model was used to model the information the term contained (27) to ensure valid statistical inference. We used the following model to test trends when serial correlation was detected:
where Y t represents the chlamydia prevalence rate or absolute disparity rate, b 0 is the intercept, X t is the trend variable representing the number of 2-month intervals since baseline, b 1 estimates the changes in the mean value of Y t per 2-month interval, and N t is the ARMA error term.
Initially, we fitted a simple regression model to test temporal trends. If the residual series did not correspond to white noise, we used a 3-stage model-building strategy to obtain an adequate ARMA model. Details of the 3-stage model-building strategy can be found elsewhere (25, 26, (28) (29) (30) . Briefly, this strategy includes model identification, model estimation, and model checking. First, a candidate ARMA model was identified for the residual series based on autocorrelation function and partial autocorrelation function plots. Next, the estimated parameter of the ARMA component that was statistically significant and satisfied the condition of stationarity-invertability was selected. Finally, the model residuals were evaluated by residual autocorrelation function plot and the Ljung-Box Q test (30) , testing up to 24 interval lags. When an adequate ARMA model was identified, the coefficient of the trend variable was estimated and tested for significance. The SAS ARIMA procedure (SAS Institute Inc., Cary, North Carolina) with maximum likelihood estimation was used to set up the models (31, 32) .
A centered, moving average smoothing technique (33) was used to more clearly illustrate the trends presented in the 2 figures. We used 5 2-month intervals as the moving time window to calculate the average value of each data point.
All statistical analyses were performed using SAS, version 9.1 for Windows. A significance level of 0.05 was employed, and all statistical tests were 2-tailed. Table 1 ). In 2008, unadjusted chlamydia prevalence determined by SDA testing of urine specimens was 11.8% among women (14.1% among black women and 6% among white women; Table 1 ), yielding an absolute difference of 8.1% (95% confidence interval: 6.8, 9.3). The smoothed trend lines declined over the 34-month period for chlamydia prevalence among black women and for racial disparity, but chlamydia prevalence among white women remained stable (Figure 1, panel A) .
RESULTS
From
In regression analyses, the residual series for the model assessing prevalence trend among black women corresponded to white noise. ARMA (1, 0) was identified as an adequate ARMA error term for the models assessing the prevalence trend among white women and the racial disparity trend among women. The black-white disparity for women significantly decreased by an average of 0.122% in each 2-month interval (P ¼ 0.019; Table 2 ). Chlamydia prevalence significantly declined among black women (À0.139%, P ¼ 0.004) but not among white women (À0.028%, P ¼ 0.413). Notably, without taking the serial correlation into account by using simple linear regression, the declining trend in the chlamydia prevalence racial disparity was not statistically significant (À0.107%, P ¼ 0.260). The black-white disparity for women significantly decreased in the Midwest (À0.385% per 2-month interval; P < 0.001) and the West (À0.115%, P < 0.001) but not in the South or Northeast.
From January 2004 through December 2008, 137,294 (99.5%) of 137,989 black and white men aged 16À24 years with a known region of residence were screened for chlamydia during their NJTP entrance examination. Among the 136,892 men who had positive or negative test results, 62.6% were black, 71.8% were aged 16-19 years, and 52.1% were from the South (Table 3) . On average, 2,855 black men and 1,708 white men were tested in each 2-month interval during the study period. Unadjusted chlamydia prevalence was high among black men aged 20-24 years (13.0%) and black men from the South (13.3%) ( Table 3 ). In 2008, unadjusted chlamydia prevalence was 8.5% for men (11.7% for black men and 2.7% for white men; Table 3) , with an absolute difference of 9.0% (95% confidence interval: 8.4, 9.6). The smoothed trend lines for chlamydia prevalence among white men and for racial disparity fluctuated over time, while the trend line for chlamydia prevalence among black men declined slightly (Figure 1, panel B) .
In regression analyses, the residual series for models assessing racial disparity, black men, and white men all corresponded to white noise. Therefore, ARMA errors were not included in any of these 3 models. The black-white disparity for men slightly decreased by an average of 0.010% per 2-month interval, but this decline was not statistically significant (P ¼ 0.568, Table 2 ). Chlamydia prevalence declined significantly among both black men (by 0.045% per 2-month interval; P < 0.001) and white men (0.035%, P ¼ 0.002). No significant changes in black-white disparity for men were detected in any of the 4 regions.
DISCUSSION
Using a time-series approach for analyzing the temporal trend of absolute black-white disparity in chlamydia prevalence, we found that the disparity for women entering the NJTP significantly declined by approximately 2% during the 34-month study period (March 2006 through December 2008), and the changes in disparity varied by region. However, the change in black-white disparity observed among men between January 2004 and December 2008 was not statistically significant overall or by region of residence. Chlamydia prevalence among black women decreased significantly over time and chlamydia prevalence among white women was stable, resulting in a decrease in the absolute black-white disparity among women. We did not see evidence of significant changes in the black-white disparity among men, but prevalence decreased among both black men and white men during the study period. Despite the decreases mentioned above, both chlamydia prevalence and the absolute black-white disparities remained high for both sexes.
Our findings of racial disparity in chlamydia prevalence and chlamydia prevalence for women and men (i.e., decreasing disparity over time) are different from disparity trends observed in national chlamydia case-report data from the same time period. The black-white disparity in chlamydia case rates increased among both women and men. However, because a number of factors, such as screening coverage, use of multiple testing methods, and variable reporting practices, affect the interpretation of morbidity data (1, 34) , prevalence trends derived from a stable screening program, such as the NJTP, may provide better information for monitoring changes in chlamydia distribution. In NJTP data, information regarding the entrants' demographic characteristics, testing methods used, and screening coverage is available to aid interpretation. During the study period, the NJTP chlamydia screening rate was consistently high (!98% of entrants were screened each year), and more than 99% of NJTP entrants were tested using only 1 chlamydia diagnostic test, SDA. Thus, the NJTP chlamydia prevalence trend data, in contrast to chlamydia case-report data, are not subject to the confounding effects of variable composition of the population being monitored, variable chlamydia screening coverage, or variable test performance. Declining chlamydia prevalence trends among NJTP female entrants have been observed during 2 previous time periods (1990-1997 and 1998-2004) (11, 13) . In a recent analysis of NJTP data from 2003-2007, Satterwhite et al. (10) focused on trend analysis of chlamydia prevalence using logistic regression and found that chlamydia prevalence decreased among young men and women regardless of race/ethnicity, age group, and region. Our findings of declining prevalence among black women and black and white men are consistent with these findings, indicating that the findings in our analysis are robust across types of measures and models. However, the finding of stable prevalence in our analysis is different from the observed decrease in prevalence among white women in Satterwhite et al.'s analysis (10) . Different statistical models (regression method vs. logistic regression) with different measures (prevalence vs. odds) and different time spans (2003-2007 vs. 2006-2008) may be the reasons for the discrepancy.
To our knowledge, our analysis is the first systematic assessment of temporal trends in the racial disparity in chlamydia prevalence among socioeconomically disadvantaged young men and women. The declining disparity among women and the declining prevalence suggest that traditional sexually transmitted disease (STD) prevention and control activities, such as surveillance, screening, clinical services, partner management, and behavioral intervention, have been effective. However, even with these decreases, chlamydia prevalence remained substantial, highlighting the ongoing need to reduce the chlamydia burden among these at-risk populations. The persistently high excess morbidity among blacks as compared with whites indicates that STD prevention and control strategies must target this population for prevention interventions. Because factors such as lack of perceived risk, limited acceptability, and limited affordability of health-care services are barriers to chlamydia prevention and control, specific prevention strategies addressing the needs of black communities may be required in order to reduce the chlamydia burden and the racial disparity (35) (36) (37) (38) . In an extensive review, Barrow et al. (38) evaluated current STD prevention and control strategies and suggested that traditional strategies need to be tailored to enhance their impact and better meet the needs of black communities. The variations in disparity trends among women across the 4 Census regions may be due to regional and racial differences in complex factors such as access to prevention and treatment services, sexual behavior, and exposure to local interventions. However, further explanation of the regional findings is confounded by limited trend data on health services by region and population subgroup. Future investigation is needed to adequately address this question.
Our analyses had several strengths. First, we efficiently used available data across the entire study period(s) without dropping interim time-series data and took serial correlation into account in the temporal data to improve the accuracy and validity of the assessment of disparity trends. Without taking the serial correlation into account, we might have concluded that the declines in the black-white disparity for women were not statistically significant. To our knowledge, this is the first application of the regression with ARMA errors method to assess racial disparity trends in chlamydia prevalence. Second, because of consistently high screening coverage rates and the use of a single test technology for several years, our study was not substantially subject to biases caused by varying screening coverage or changing test technology across population subgroups over time. Third, we used a direct standardization method to adjust bimonthly chlamydia prevalence over time; thus, the confounding effect caused by varying distributions of age group, test specimen type (for women only), or Census region of residence across time was controlled.
Our study was subject to several limitations. First, the study population-socioeconomically disadvantaged young adults-is considered to be at high risk for acquisition of STDs; therefore, our findings cannot be generalized to other populations. However, NJTP participants are more homogenous with respect to income and socioeconomic status than a general population, so our analysis allowed less confounded comparisons of chlamydia prevalence between blacks and whites over time. Second, the error pattern for each of the 6 models was identified and tested on the basis of the statistical model-building strategy, as described in the Materials and Methods section. Two different types of error patterns were obtained, white noise and ARMA (1, 0). Geographic, network, or other factors may have produced the differences, but we did not have data with which to test these hypotheses. Finally, only 3 years of prevalence data were analyzed for women during the study period; the trends might not have been stable if we had observed the women over a longer time period, particularly in the regional subanalysis. Further monitoring of chlamydia prevalence and disparity in this sentinel population is needed. In summary, using a time-series approach, we found that with the significant decrease in chlamydia prevalence among black women and stable prevalence among white women, the black-white disparity among women entering the NJTP improved during the study period. Although significant changes in the absolute disparity among men were not observed, chlamydia prevalence among both black men and white men declined. Even with these decreases, chlamydia prevalence remains high, and excess chlamydia prevalence among blacks as compared with whites was persistently high for both sexes. These findings suggest that current chlamydia control efforts may be reaching young black men and women but need to be scaled up or modified to address the excess risk among the socioeconomically disadvantaged young blacks. Further monitoring of chlamydia prevalence and disparity and potential explanatory variables (e.g., chlamydia screening access and coverage) in this sentinel population is warranted to determine whether the temporal trends will stabilize or change.
